| 中文别名 |
奈伟拉平;那韦拉平;萘维拉平;奈韦那平;萘韦拉平;11-环丙基-5,11-二氢-4-甲基-6H-二吡啶并[3,2-B:2',3'-E][1,4]二氮杂革-6-酮;奈夫拉平;(34-二甲基苯氧基)-乙酸肼;3,5,6三氯-4-羟基皮考啉酸;Nevirapine 奈韦拉平;奈韦拉平;奈韦拉平 EP标准品;奈韦拉平 标准品;奈韦拉平-D5;奈韦拉平用于峰签定 EP标准品;无水奈韦拉平;无水奈韦拉平 USP标准品;11-环丙基-5,11-二羟基-4-甲基-6H-二吡啶并[3,2-b:2',3'-e][1,4]二氮杂唑-6-酮;奈韦拉平,那韦拉平;11-环丙基-5,11-二氢-4-甲基-6H-二吡啶并[3,2-b:2',3'-e][1,4]二氮杂卓-6-酮;那伟拉平;奈韦拉平(标准品);奈韦拉平 NEVIRAPINE;奈韦拉平(对照品);奈韦拉平(无水) |
| 英文别名 |
11-Cyclopropyl-4-methyl-5H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6(11H)-one;11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B',3'-E][1,4]DIAZEPIN-6-ONE;5-CYCLOPROPYL-9-METHYL-5,10-DIHYDRO-4,5,6,10-TETRAAZA-DIBENZO[A,D]CYCLOHEPTEN-11-ONE;6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE, 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-;NEVIRAPINE;VIRAMUNE;Novirapine*;Nevirapine(Nvp);NEVIRAPINE(SUBJECTTOPATENTFREE);Viramune (Nevirapine);BI-RG-587;Viramnune;5H-Dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one, 5,11-dihydro-11-cyclopropyl-4-methyl-;11-Cyclopropyl-4-methyl-11H-dipyrido[3,2-b:2',3'-e][1,4]diazepine-6(5H)-one;4-Methyl-11-cyclopropyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one;5,11-Dihydro-11-cyclopropyl-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one;11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one;11-cyclopropyl-4-methyl-5H-dipyrido[2,3-e:2',3'-f][1,4]diazepin-6-one;11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-6：2’,3’-e][1,4]diazepin-6-one;11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one;11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2’,3’-][1,4] diazepin-6-one;BI-RG 587;Nevirapine Anhydrous;NSC 641530;NVP;11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2′,3′-e][1,4]diazepin-6-one;D00435;Nevirapil;Nevarapine;AIDS005653;Nevirapine;11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one;HMS3371E03;HY-10570;NSC641530;MFCD00866928;AB00393001-13;11-cyclopropyl-4-methyl-5H-dipyrido[[?],[?]][1,4]diazepin-6-one;BIRG 587;NEVIRAPINE [JAN];Viramune (TN);Nevirapine [USAN:USP:INN:BAN];NEVIRAPINE [VANDF];NS00004959;2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-10-one;HSDB 7164;NEVIRAPINE [HSDB];MLS000759409;KS-5019;Tox21_110982_1;BIRG-587;BIDD:GT0326;Nevirapine (JAN/USP/INN);NEVIRAPINE [MART.];Q263713;EN300-119500;Nevirapine,(S);BIRG0587;NCGC00065890-04;CHEBI:63613;BI-RG-587; BIRG 0587; BIRG587; HSDB 7164; NSC 641530; NVP;Nevirapine anhydrous, United States Pharmacopeia (USP) Reference Standard;S1742;Tox21_110982;N11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e]-[1,4]diazepin-6-one & CD4-immunoadhesin;NON-NUCLEOSIDE RT INHIBITOR NEVIRAPINE;HMS3393J09;MLS006011423;Viramune IR;Viramune(TM);Nevirapine & PRO 140;AB00393001_17;Nevirapine, anhydrous;C07263;AB00393001-15;Nevirapine);Tox21_200770;BIRG 0587;NCGC00065890-14;GTPL12676;AB00393001_16;NCGC00065890-07;BI-RG 587;NSC 641530;NVP;99DK7FVK1H;11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b :2',3'-e][1,4 ]diazepin-6-one;Nevirapine for peak identification;BDBM1434;BI-RG-587 & CD4-IgG;Nevirapinum anhydrous;AC1280;BCP05587;NEVIRAPINUM ANHYDROUS [WHO-IP LATIN];MLS001201730;DB00238;BIRG587;MLS001424058;NEVIRAPINE ANHYDROUS [USP-RS];NC00189;HMS3264D21;DTXSID7031797;NCGC00065890-02;SW197569-2;AKOS0055... |
微信公众号
客服
